NTT-COMMUNICATIONS
27.3.2024 01:01:32 CET | Business Wire | Press release
NTT Communications Corporation (NTT Com) and the Hokuriku Regional Office of NTT DOCOMO, INC. (DOCOMO), together with the city of Kanazawa, celebrated the opening of a new section of the Hokuriku Shinkansen Line between Kanazawa and Tsuruga by holding digital events on March 16 under the theme of "Connection," a key component of NTT Group’s Innovative Optical and Wireless Network (IOWN) concept.1
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240325762257/en/
Scheme of live remote performance (Graphic: Business Wire)
The events included a live remote performance that seamlessly connected musicians in Kanazawa and Tokyo, a distance of about 1,000 kilometers, via the All-Photonics Network (APN). For the connection, NTT Com provided its APN Leased Line Plan powered by IOWN,2 which used the longest optical cable ever deployed in an IOWN demonstration and the first to be deployed in Japan's Hokuriku region.
The event brought together the Kanazawa Junior Jazz Orchestra JAZZ-21, consisting mainly of middle and high school students who have performed at the areas affected by the Great East Japan Earthquake and various major festivals around the world, and celebrated violinist Mayu Kijima, winner of numerous international competitions, including the 1st Shanghai Isaac Stern International Violin Competition in 2016, who performed with the Walner violin made by Antonio Stradivari 1699, which was on loan from the Munetsugu Collection.
Kanazawa City provided the demonstration environment and operated the venue in its area and NTT Com provided the APN transmission equipment and the venue in Tokyo. NTT Com and DOCOMO livestreamed the event on Kanazawa's metaverse platform using DOCOMO's 5G video transmission system, allowing viewers at home to enjoy the live event on PCs, smartphones and tablets via the browser-based virtual space platform DOOR.3 In addition, DOCOMO used its Hide Mode4 function to allow more people than normal to enter the virtual room. This was the first time in Japan that a metaverse space open to the public was used for a music event.
In another demonstration, smart lighting was used to allow spectators to digitally interact with Kanazawa's famous Tsuzumi-mon Gate to influence its illumination on the evening of March 16. Using 5G communication and IoT technology, spectators were able change the illumination by selecting from eight patterns via tablets placed near the gate. The demonstration, called “Connecting with Tsuzumi-mon Gate,” allowed people to make a special connection with the iconic site, including to take commemorative photos.
A third commemorative demonstration on March 16, called “Connecting with Other Locations,” allowed visitors to the Underground Plaza of the Motenashi Dome near Kanazawa Station to view and experience famous scenes along the Hokuriku Shinkansen line via a wide-angle virtual reality display without the use of goggles. During the demonstration, multiple people simultaneously enjoyed videos, 360-degree images and metaverse spaces, and even the experience of sitting in a Shinkansen driver's seat while traveling on the newly extended Hokuriku Shinkansen line.
DOCOMO group, under an agreement signed with the city of Kanazawa and West Japan Railway Company in 2019, is working to promote local attractions using 5G and other advanced technologies. Following the recent Noto Peninsula Earthquake on January 1, DOCOMO has strengthened its efforts to work with the people of the Hokuriku region to revitalize the region and support its recovery and reconstruction. Going forward, based on the lessons learned from the event to commemorate the Hokuriku Shinkansen Line's extension, NTT Com and DOCOMO are committed to providing new value to Kanazawa citizens and customers by incorporating new technologies, including the IOWN APN where possible, to promote the attractiveness of Kanazawa and contribute to the revitalization of the region.
1 Network infrastructure concept for creating an enriched society using advanced optical technologies, etc. IOWN® is a trademark of NTT Corporation. https://www.rd.ntt/e/iown/
2 NTT Com began offering APN communication services spanning prefectures from March 1 to meet customers' needs for advanced communication infrastructure.
3 DOCOMO's subsidiary NTT QONOQ INC. (https://www.nttqonoq.com/?lang=en) provides this service for holding events and displaying content in virtual spaces.
4 While 24 people is the normal recommended capacity of a virtual room, Hide Mode is a paid option that allows hundreds of people to enter, with certain limited capabilities. Please visit https://door.ntt/web/faq/index.html.
About NTT Communications
NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, the world's most advanced data-center facilities (more than 500,000m2) and cutting-edge technologies for cloud, security and AI. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities, leveraging 5G, IoT and other technologies under the "docomo business" brand. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com
About NTT DOCOMO
NTT DOCOMO, Japan’s leading mobile operator with over 89 million subscriptions, is one of the world’s foremost contributors to 3G, 4G and 5G mobile network technologies. Beyond core communications services, DOCOMO is challenging new frontiers in collaboration with a growing number of entities ("+d" partners), creating exciting and convenient value-added services that change the way people live and work. Under a medium-term plan toward 2020 and beyond, DOCOMO is pioneering a leading-edge 5G network to facilitate innovative services that will amaze and inspire customers beyond their expectations.
https://www.docomo.ne.jp/english/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240325762257/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom